Emily DiMango M.D.

Associate Professor of Clinical Medicine
Director, John Edsall-John Wood Asthma Center
Director, Adult Cystic Fibrosis Program

Bio

Education and Training

Undergraduate:
B.S. at New York University, summa cum laude, New York, New York, 1984
Medical School:
New York University School of Medicine, New York, New York, 1989
Internship:
Internal Medicine, NewYork-Presbyterian/Columbia University Medical Center, New York, New York, 1989-1990
Residency:
Internal Medicine, NewYork-Presbyterian/Columbia University Medical Center, New York, New York, 1990-1992
Fellowship(s):
Pulmonary Division, NewYork-Presbyterian/Columbia University Medical Center, New York, New York, 1992-1996

Honors and Awards

  • 1984 Phi Beta Kappa, New York University, New York, New York
  • 1984 Brown Award for excellence in Chemistry, New York University
  • 1993 Teaching Award in Pulmonary Medicine
  • 1994-1996 J. Amberson Burns Fellow of American Lung Association

Clinical

For appointments: 

Contact: Ida Soler Cruz
622 W. 168th Street
PH 8-Center
New York, NY 10032
P: (212) 305-0631
F: (212) 342-4784

Specialties

  • Pulmonary Disease Medicine

Clinical Expertise

  • Adult cystic fibrosis
  • Bronchiectasis
  • Asthma

Clinical Centers

Board Certifications

  • Internal Medicine Diplomate, 1992, 2006
  • Pulmonary Disease Diplomate, 1994, 2005

Research

Contact Information: 

E.DiMango Laboratory

Research Interests

  • Adult CF
  • Bronchiectasis
  • Asthma

Selected Publications

  1. Boushey, H, Sorkness, C, King, DiMango, E, et al. Regular vs. intermittent controller therapy for mild persistent asthma. New England Journal of Medicine. 2005.
  2. Deykin, A, Lazarus, S…. DiMango, E. Sputum Eosinophils Predict Asthma Control Following Discontinuation of Inhaled Corticosteroids. Journal of Asthma and Clinical Immunology 2005; 115(4): 720-727.
  3. Wechsler ME, Lehman E, Lazarus, DiMango, E….. Beta adrenergic receptor polymorphisms and response to salmeterol. Beta-adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med. 2006; 173(5):519-26.
  4. Deykin A, Wechsler ME, Boushey HA,… DiMango, E…. Combination therapy with a long acting b-agonist and a leukotriene antagonist in moderate asthma. Am J Respir Crit Care Med 2007 Feb 1;175 (3):228-34.
  5. Martin, RJ, Szefler, SJ, King T….DiMango, E… The Predicting Response to Inhaled Corticosteroid Efficacy. Journal of Asthma and Clinical Immunology 2007 Jan; 119(1):73-80
  6. Lazarus, SC, Chinchilli VM, Rollings NJ…DiMango E, … Smoking Affects Response to Inhaled corticosteroids or leukotriene receptor antagonists in Asthma. Am J Respir Crit Care Med. 2007
  7. American Lung Association Asthma Clinical Research Centers; Mastronarde, JG, Wise RA, Shade DM, Olopade, CO, Scharf, SM. Sleep quality in asthma: results of a larage prospective clinical trial. J Asthma. 2008 Apr, 45 (3): 183-9.
  8. American Lung Association Asthma Clinical Research Centers; Mastronarde, JG, Anthonisen, NR, Castro M, Holbrook, JT, Leone FT. Efficacy of esomeprazole for treatment of poorly controlled asthma. NEJM. 2009 Apr 9; 360 (15): 1487-99.
  9. **DiMango, E, Holbrook, J, Simpson, Reibman, J, Richter, J, Mastronarde, J, Wise, R for the American Lung Association Asthma Clinical Research Centers. Effects of Asymptomatic Proximal and Distal Gastroesophageal Reflux on asthma severity, AJRCCM 2009, epub
  10. **Keating, C, Liu, X, DiMango, E. Clinical and demographic characteristics of patients diagnosed with cystic fibrosis after the age of 18, under review.

View Dr. DiMango's full list of publications from PubMed